Overcoming oligonucleotide manufacturing challenges, Trishul Shah, TIDES USA 2023

(8:16)

Overcoming oligonucleotide analysis challenges with Intertek

(5:6)

Overcoming Oligonucleotide Manufacturing Challenges, Loïc Cornelissen, TIDES ASIA

(18:31)

Fixing Genes with Antisense Oligonucleotides (ASOs)

(2:13)

Webinar | Considerations for Developing IP-RP Methods for Oligonucleotide Analysis

(26:26)

Can Antisense Oligonucleotides REALLY Cure Genetic Disorders?

(15:36)

Submerge in the Oligonucleotide Emerge: Best Practices for Developing These Complex Biologics

(1:7:7)

Educational video oligo synthesis

(1:38)

Developing next-generation oligonucleotide therapeutics

(6:54)

Therapeutic Oligonucleotide Discovery \u0026 Development: Development Day 2

(55:48)

How Does It Work? | Oligonucleotide Therapies

(1:24)

Oligonucleotide Synthesis for Therapeutics

(2:49)

ASF Scientific Symposium: Hurdles to be Overcome for a Trial of Oligonucleotide Therapy in AS

(12:26)

Antisense Oligonucleotides: An Emerging Area in Drug Development

(2:31)

Regulatory Applications of a Nonclinical Database for Oligonucleotide Therapeutics at U.S. FDA

(25:14)

How to design antisense oligonucleotides for high on-target potency and minimal off-target effect

(49:46)

What is Oligonucleotide Synthesis?

(4:9)

Structural Characterization of Short Oligonucleotide Therapeutics by Solution NMR

(26:7)

What are oligonucleotide therapeutics, and how do they work?

(9:25)

Quantification Methods for oligonucleotide therapeutics in serum and tissue

(35:)